Skip to content
  • News Feed
  • Top News
  • Headlines
  • Videos
MarketNewsData
Essential Market News. Zero Noise.
  • News Feed
  • Top News
  • Headlines
  • Videos

Category: Markets

NVIDIA stock dropped 21% due to fears over Chinese AI startup, but remains strong.

From Zacks Investment Research: 2025-02-05 05:52:13 Zacks.com highlighted stocks in their Analyst Blog, including NVIDIA Corp., Marvell Technology, Broadcom Inc.,

February 5, 2025

Indian shares close slightly lower after rally, with some specific stocks falling and others rallying

From Nasdaq: 2025-02-05 05:23:14 Indian shares closed slightly lower on Wednesday after a previous rally. U.S.-China trade tensions continue, with

February 5, 2025

Billionaire investors are buying high-yield dividend stocks such as Sirius XM, CVS Health, Philip Morris

From Nasdaq: 2025-02-05 04:51:00 The stock market has been soaring in 2023, with the Dow Jones, S&P 500, and Nasdaq

February 5, 2025

Trump's focus on Iran causes risk appetite to decline, while gold prices skyrocket

From Investing.com: 2025-02-05 04:34:00 President Trump chose to remain silent on the issue of tariffs and instead focused on geopolitics,

February 5, 2025

CNH employees in Italy to receive performance bonus based on 2024 individual and collective performance.

From GlobeNewswire: 2025-02-05 04:00:00 CNH annuncia l’erogazione del premio di risultato per il 2024 ai dipendenti in Italia. I valori

February 5, 2025

Match Group stock has underperformed but analysts are optimistic about its future

From Barchart: 2025-02-05 03:18:51 Match Group, Inc. has not performed well compared to the overall market in the last year.

February 5, 2025

Alfa Laval acquires NRG Marine to meet demand for anti-fouling technology

From Nasdaq: 2025-02-05 03:16:07 Alfa Laval AB has announced the acquisition of NRG Marine, a provider of ultrasonic anti-fouling solutions.

February 5, 2025

Crédit Agricole Assurances had a successful 2024, setting record premium income levels

From GlobeNewswire: 2025-02-05 02:34:49 In 2024, Crédit Agricole Assurances saw record activity with premium income reaching 43.6 billion euros, a

February 5, 2025

Gold prices surge by 1% as trade tensions and weakening dollar drive safe-haven flows.

From Investing.com: 2025-02-05 02:19:00 Gold prices surged by 1% on Tuesday as trade tensions between the US and China persisted,

February 5, 2025

Positive. Macro and liquidity conditions remain positive for risk assets, with equities outperforming in January.

From Investing.com: 2025-02-05 01:30:00 Overall, the macro & liquidity conditions are still positive for risk assets, with an overweight stance

February 5, 2025

Equinor reports Q4 net income decrease, plans dividend and $5 billion share buyback

From Nasdaq: 2025-02-05 01:11:11 Equinor ASA reported a 23% decrease in fourth-quarter net income to $2 billion, with basic earnings

February 5, 2025

Indian shares hold steady after strong rally driven by optimism over easing tariff concerns and RBI rate cut

From Nasdaq: 2025-02-04 23:24:16 Indian shares remained steady on Wednesday after a strong rally the day before, driven by optimism

February 4, 2025

Husqvarna Group partners with Flex Ltd. to divest manufacturing operations in South Carolina

From Nasdaq.: 2025-02-04 22:28:23 Husqvarna Group partners with Flex Ltd. to divest manufacturing operations in South Carolina. Flex will produce

February 4, 2025

Asian markets trade mixed amid concerns about global trade war

From Nasdaq: 2025-02-04 22:17:53 Asian stock markets are trading mixed on Wednesday amid concerns about a global trade war. Australian

February 4, 2025

GH Research prices $150 million public offering with focus on developing mebufotenin therapies

From GlobeNewswire: 2025-02-04 20:52:00 GH Research PLC has priced its underwritten public offering in the US, offering 10,000,000 ordinary shares

February 4, 2025

FDA approves Genentech's Susvimo for diabetic macular edema, positive.

From Nasdaq MarketSite: 2025-02-04 20:44:21 The FDA has approved Genentech’s Susvimo for diabetic macular edema, a leading cause of vision

February 4, 2025

Palantir Technologies stock surged over 20% after strong Q4 results, showcasing positive growth and outlook.

From Zacks Investment Research.: 2025-02-04 20:32:14 Palantir Technologies (PLTR) stock surged over +20% in Wednesday’s trading session after reporting strong

February 4, 2025

China stock market ends two-day winning streak, optimism about trade war ease, global markets up.

From NASDAQ MarketSite: 2025-02-04 20:01:12 The China stock market ended a two-day winning streak ahead of the Lunar New Year

February 4, 2025

Topicus.com Inc. acquires more shares of Asseco Poland S.A., expanding its presence in the market.

From GlobeNewswire: 2025-02-04 19:45:27 Topicus.com Inc. and Constellation Software Inc. announced that Topicus’ subsidiary, Yukon, will acquire 14.84% of Asseco

February 4, 2025

Positive - Palantir reports strong Q4 earnings with significant growth in sales and contract value

From Zacks Investment Research: 2025-02-04 19:12:14 The 2024 Q4 earnings cycle is positive overall, with Palantir (PLTR) reporting strong results,

February 4, 2025

Regeneron Pharmaceuticals stock rose nearly 5% after impressive Q4 results and positive guidance for 2025.

From Nasdaq: 2025-02-04 18:44:42 Regeneron Pharmaceuticals (NASDAQ: REGN) saw a nearly 5% share price gain after posting impressive fourth-quarter and

February 4, 2025

Nancy Pelosi's stake in Tempus AI boosts stock nearly doubling, with outlook for significant growth.

From Zacks Investment Research.: 2025-02-04 17:52:17 Zacks used to have a service called “Follow the Money” that tracked institutional investor

February 4, 2025

NOV Inc. reported lower Q4 income of $160 million, beating estimates

From Nasdaq: 2025-02-04 17:50:33 NOV Inc. (NOV) reported a fourth-quarter profit of $160 million, or $0.41 per share, which was

February 4, 2025

RedHill Biopharma starts Phase 2 trial for advanced prostate cancer treatment using opaganib

From Nasdaq: 2025-02-04 17:26:39 RedHill Biopharma has started a Phase 2 trial to evaluate opaganib’s effectiveness in enhancing darolutamide for

February 4, 2025

Diversified Royalty Corp declares $0.02083 dividend per share for February 2025

From GlobeNewswire: 2025-02-04 17:05:00 Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) declares a cash dividend of $0.02083 per common share

February 4, 2025

Posts pagination

Previous 1 … 1,085 1,086 1,087 … 1,404 Next
All Right Reserved © MarketNewsData.com.

Saved Articles

No saved articles yet.

  • News Feed
  • Top News
  • Headlines
  • Videos
  • Contact Us
  • About Us
  • CCPA
  • Terms of Use
  • Privacy Policy
  • DMCA
Home

Search

Categories

  • Business (31,705)
  • Crypto (15,204)
  • Default (19)
  • Earnings (7,117)
  • Finance (25,772)
  • Investing (49,402)
  • Markets (35,090)
  • Smart Data (143)
  • Top News (9,230)
    • Videos (3,764)

Saved Articles

No saved articles yet. Tap the bookmark icon on any article to save it for later.